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Abstract
Background: In Japan, discussion concerning advance directives (ADs) has been on the rise during
the past decade. ADs are one method proposed to facilitate the process of communication among
patients, families and health care providers regarding the plan of care of a patient who is no longer
capable of communicating. In this paper, we report the results of the first in-depth survey on the
general population concerning the preferences and use of ADs in Japan.
Method: A self-administered questionnaire was sent via mail to a stratified random sampling of
560 residents listed in the residential registry of one district of Tokyo, Japan (n = 165,567).
Association between correlating factors and specific preferences toward ADs was assessed using
contingency table bivariate analysis and multivariate regression model to estimate independent
contribution.
Results: Of the 560 questionnaires sent out, a total of 425 participants took part in the survey
yielding a response rate of 75.9 %. The results of the present study indicate that: 1) the most
important components to be addressed are the specifics of medical treatment at the end of life
stage and disclosure of diagnosis and prognosis; 2) the majority of participants found it suitable to
express their directives by word to family and/or physician and not by written documentation; 3)
there is no strong need for legal measures in setting up an AD; 4) it is permissible for family and
physician to loosely interpret one's directives; 5) the most suitable proxy is considered to be a
family member, relative, or spouse. Multivariate analysis found the following five factors as
significantly associated with preferences: 1) awareness regarding living wills, 2) experience with the
use of ADs, 3) preferences for end-of-life treatment, 4) preferences for information disclosure, and
5) intentions of creating a will.
Conclusions: Written ADs might be useful in the Japanese setting when the individual either
wishes: 1) to not provide a lot of leeway to surrogates and/or caregivers, and/or 2) to ensure his
or her directives in the cases of terminal illness, brain death, and pain treatment, as well as regarding
information disclosure.
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Background
Advance directives (ADs) are one method proposed to
facilitate the process of communication among patients,
families and health care providers regarding the plan of
care of a patient who is no longer capable of communicat-
ing. ADs are made while the patient is still competent;
they specify the course of medical treatment to be pro-
vided by caregivers and/or designate someone to act as a
proxy should the patient lose his or her capacity to make
decisions.
In the United States, the moral arguments supporting ADs
are based primarily on the concept of respect for auton-
omy or on the patient's right to self-determination. The
Patient Self-Determination Act of 1990 aims to encourage
patients to take the initiative to ensure that their values are
respected at the end of their life [1]. Completion of formal
documentation either in the form of ADs or durable pow-
ers of attorney are considered to be effective means in sup-
porting patient autonomy and patient preferences
regarding life-sustaining treatment. ADs and the use of a
health care proxy have been recommended as a means to
improve communication about the patient's preferences
in making health care decisions [2–4].
Other research indicates that ADs should contain disease-
specific information rather than general statements which
do not offer much assistance in clinical situations, and
should be seen as part of a more general plan for end-of-
life decisions in which improved communication would
be more important than a more formal preservation of
rights, achieved by simply completing a document [3,5–
7]. However, whether the disease-specific ADs really
improve the patient-physician relationship has not yet
been confirmed [8]. Moreover, several studies demon-
strated that not many people execute ADs even when
legally warranted as in the United States [9,10].
The factors of ethnicity and culture on the process of deci-
sion-making for end-of-life treatment have increasingly
become a paramount issue to AD related research [2,11–
14]. The significance of culturally shaped values has been
described in studies between African American and white
patients, Chinese and non-Chinese seniors as well as
between other Asian subgroups. In particular, patients'
respective religious and philosophical traditions are con-
sidered to be in direct correlation with attitudes towards
end-of-life decision-making.
In Japan, discussion concerning patient autonomy and
the significance of patient determination wishes has been
incessantly on the rise during the past decade within aca-
demic circles as well as in the mass media [15]. Several
studies have been conducted including questionnaires
and interviews to physicians [16–18], questionnaires to
the elderly [19], and brief nationwide pool surveys,
although only having consisted of a few straightforward
questions [20,21]. While these studies have shown a grad-
ual gain in attention and recognition of the meaning of
ADs in Japan, there is to this date no in-depth survey of
the general public's preferences, attitudes and behavior
regarding ADs. According to our previous preliminary
study conducted in 1996 on over 200 healthy males, we
observed a general positive attitude towards ADs and a
large amount of leeway regarding the carrying out of one's
directives [22].
Based on these findings, our present study serves as the
first stratified sampling in-depth survey of laypersons'
preferences and behaviors regarding ADs. This study has
the following objectives: 1) to identify preferences
towards ADs as well as attitudes, awareness, experience, 2)
to determine the factors associated with those preferences,
and 3) to provide data to serve as a foundation for later
investigating suitable ways of implementing ADs in Japan.
Participants and methods
A self-administered questionnaire was sent via mail to a
stratified random sampling of 560 residents listed in the
residential registry of one district of Tokyo, Japan (n =
165,567) in May of 1998. This list, which is divided by
town, constitutes addresses of all residences in alphabeti-
cal order. We gained access to it after receiving approval
from the head of the district. 14 towns were first randomly
chosen from 69 towns within the defined area (sampling
rate: 1/5). Participants were then randomly selected from
each of the 14 areas based on the population size of each
town (sampling rate: 1/60). The total sampling rate was 1/
300. In the cover letter, it was made clear that the ques-
tionnaire was research-related, completely participatory
and that all respondents would be treated anonymously.
All questionnaires were collected either by return mail or
by dispatched students.
The questionnaire is composed of 13 questions designed
to delineate participants' awareness, preferences, attitudes
and behavior towards ADs and advance care planning as
well as to deconstruct the specific factors underlying par-
ticipants' specific decision-making processes regarding
ADs (Appendix 1) [see Additional file 1]. Preferences
toward ADs (Question 3 in the appendix) were set as a
dependent variable. Association between correlating fac-
tors and specific preferences toward ADs was assessed
using contingency table analysis. Factors identified in
bivariate analyses as being significantly associated with
one's preference towards ADs were entered into a multi-
variate regression model to estimate independent contri-
bution. A p value less than 0.05 was considered
significant. Data analysis was performed using SPSS 10.0
J.BMC Medical Ethics 2003, 4 http://www.biomedcentral.com/1472-6939/4/5
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Results
Response rate and socio-demographic characteristics of 
the respondents
Of the 560 questionnaires sent out, 4 were returned due
to an incorrect address. 341 questionnaires were returned
via-mail within 3 weeks, and later dispatched students
collected 84. 19 respondents informed us that they
decided not to participate in the survey. In total, 425 par-
ticipants took part in the survey, yielding a response rate
of 75.9 %. Socio-demographic characteristics, experience
with hospitalization and death as well as self-rated health
status are shown in Table 1. The mean age of respondents
was 44.7 years of age with a SD 14.2. The majority had
junior college level education and more than 70% of par-
ticipants claimed to be non-religious. While less than 20%
of respondents had hospitalization experience in the past,
over 40% have had a family member with such experi-
ence. Over 50% of respondents have had a family mem-
ber, relative or friend pass away in the last five years.
Approximately 90% of respondents rated their health sta-
tus as good or fairly good.
Awareness regarding living wills
156 respondents (36.7%) claimed to know of living wills
and 170 respondents (40.0%) replied that they have
heard of the terms but were unfamiliar with their mean-
ing. 97 (22.8%) respondents answered that they were
unaware of the terms and two people (0.5%) did not
answer. Of the 156 who responded to know of living wills
and ADs, only 12 (7.7%) respondents had actually written
one out. 139 (89.1%) answered that they had not written
one and five (3.2%) did not answer.
Preferences toward ADs: a dependent variable
In the case of suddenly becoming ill or getting into an
accident where one looses all capability to communicate,
Table 1: Socio-demographic characteristics (n = 425)
(%)
Sex Male 237 (55.8)
Female 188 (44.2)
Age 20–29 91 (21.4)
30–39 65 (15.3)
40–49 88 (20.7)
50–59 105 (24.7)
60 and over 76 (17.9)
Education Junior High School 28 (6.6)
High School 105 (24.7)
Junior College 74 (17.4)
University / College 205 (48.2)
N.A. 13 (3.1)
Occupation Self-employed 74 (17.4)
Full-time 192 (45.2)
Part-time 35 (8.2)
Unemployed 93 (21.9)
Other 19 (4.5)
N.A. 12 (2.8)
Religion Buddhism 69 (16.2)
Shinto 8 (1.9)
Christian 12 (2.8)
Other 13 (3.1)
None 307 (72.2)
N.A. 16 (3.8)
Self-rated Health Status Good 144 (33.9)
Fairly good 236 (55.5)
Fairly poor 33 (7.8)
Poor 6 (1.4)
N.A. 6 (1.4)
Experience with hospitalization and death Yes (%) No(%) N.A
Hospitalization (yourself) 65 (15.3) 326 (76.7) 34 (8.0)
Hospitalization (family member) 178 (41.9) 224 (52.7) 23 (5.4)
Family member, relative or friend's death 220 (51.8) 179 (42.1) 26 (6.1)BMC Medical Ethics 2003, 4 http://www.biomedcentral.com/1472-6939/4/5
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115 (27.1%) respondents "strongly agreed" and 227
(53.4%) respondents "moderately agreed" that it is better
to have expressed one's wishes regarding medical treat-
ment in advance. Conversely, 78 (18.4%) respondents
"moderately disagreed" and 5 (1.2%) respondents
"strongly disagreed."
Reasons for ADs
Table 2 shows reasons for wanting to express one's wishes.
The most popular reason for wanting to express one's
wishes with more than 60% responses were "I want to
undergo the treatment of my choice", "I hope to not bur-
den my family with end-of-life decisions", and "I want to
decide for myself."
Contents to be noted in one's AD
Table 3 exemplifies the requested contents to be noted in
one's AD. Four items in particular were indicated by more
than 70% of respondents: treatment related decisions in
the case of becoming terminally ill; brain death or long-
term comatose; treatment related decisions regarding
"pain" during terminal stages; and preferences for infor-
mation disclosure.
Degree of detail in one's AD
Regarding the degree of detail of one's preferences in the
AD, only 22 (6.4%) of respondents specified "as detailed
as possible," 263 (76.9%) respondents indicated "general
preferences," 15 (4.6%) respondents marked "other," 29
(8.5%) claimed to "do not know" and 13 (3.8%) did not
answer.
Degree of leeway regarding one's AD
Upon the supposition that one has created an AD, the
majority of respondents (234, 68.4%) claimed that they
would like to be treated according to one's AD "as much
as possible; however the AD does not need to be strictly
observed when seen reasonable." Only 45 (13.2%)
responded with "in absolute accordance," 37 (10.8%)
respondents indicated "just as a reference," 4 (1.2%)
respondents marked "others," 12 (3.5%) respondents
specified "do not know" and 10 (2.9%) did not answer.
Recording of one's AD and one's attitude toward 
legalization
Regarding the means of how one would like to record his
or her AD, 166 (48.5%) of respondents specified "written
document," 145 (42.4%) respondents indicated "orally to
a family member or acquaintance," 2 (0.6%) respondents
marked "other," 22 (6.4%) claimed to "do not know" and
7 (2.0%) did not answer. Of the 166 who indicated "writ-
ten document," 90 (54.2%) specified that the legalization
of ADs is "necessary," while 40 (24.1%) of respondents
claimed it to be "unnecessary," 33 (19.9%) marked "do
not know" and 3 (1.8%) of respondents did not answer.
Reasons against the use of ADs
Table 4 describes the reasons for not wanting to express
one's wishes. Four reasons were indicated by more than
40% of respondents: "My family will make such decisions
when the time is needed"; "My physician will make such
Table 2: Reasons for ADs (n = 342)
Questions Yes (%)
I want to undergo the treatment of my choice 231 (67.5)
There may be differences in opinions between family 
members
112 (32.7)
This issue has become a topic in the mass media 20 (5.8)
An acquaintance has spoken of this issue 8 (2.3)
I hope to not burden my family with end-of-life 
decisions
230 (67.3)
I want to make known my wishes regarding being a 
donor
92 (26.9)
I want to seriously consider my end-of-life decisions 98 (28.7)
I do not trust the current medical profession 26 (7.6)
I want to decide for myself 214 (62.6)
I am aware that I could possibly loose my decision 
making power as a result of becoming seriously ill or 
injured.
69 (20.2)
Others 29 (8.5)
Above are obtained from those who chosen either "strongly agree" or 
"moderately agree" in question 3 (preference toward ADs). Data 
indicate the number of respondents who marked each item.
Table 3: Contents to be noted (n = 342)
Questions Yes (%)
Treatment related decisions in the case of becoming 
terminally ill. (e.g. whether or not you wish to 
receive life-extending treatment.)
278 (81.3)
Treatment related decisions regarding "pain" during 
terminal stages. (e.g. whether or not you wish to be 
treated with painkillers.)
258 (75.4)
Whether or not you would like be informed of your 
diagnosis and prognosis. (e.g. whether or not you 
would like all information to be directly disclosed to 
you.)
247 (72.2)
Treatment related decisions in the case of brain 
death or long-term comatose.
275 (80.4)
Expressing whether or not you would like to be a 
donor for transplantation.
155 (45.3)
Expressing whether or not you would like to donate 
your body for educational purposes.
122 (35.7)
Treatment related decisions regarding end-of-life 
decisions. (e.g. whether you would like to die in the 
hospital.)
119 (34.8)
Others 16 (4.7)
Above are obtained from those who chosen either "strongly agree" 
or "moderately agree" in question 3 (preference toward ADs). Data 
indicate the number of respondents who marked each item.BMC Medical Ethics 2003, 4 http://www.biomedcentral.com/1472-6939/4/5
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decisions when the time is needed"; "I am currently
healthy and there is no need to consider such decisions";
and "It is impossible to think of such decisions for it is
impossible to imagine oneself in such a situation."
Experience with the use of ADs
In reply to the question of whether or not one has ever
thought that it was good that an acquaintance, friend or
family member made an AD, the vast majority of respond-
ents (358, 84.2%) indicated "no" while 53 (12.5%) spec-
ified "yes," 14 (3.3%) did not answer.
Preferences for end-of-life treatment
Upon the supposition that one is in extreme pain and
death is approaching with no hope of recovery, the major-
ity of respondents (196, 46.1%) agreed and 174 (40.9%)
of respondents fairly agreed "to refuse all life-sustaining
treatment and elect only to have the pain subdued" while
only 9 (2.1%) disagreed and 30 (7.1%) moderately disa-
greed "to have life-sustaining treatment regardless of the
pain." 16 (3.8%) respondents did not answer.
Preferences for information disclosure
Once again, upon the supposition that one is in extreme
pain and your death is approaching with no hope of
recovery, the majority of respondents (193, 45.4%)
agreed and 150 (35.3%) of respondents fairly agreed "to
have all information concerning your diagnosis, etc. dis-
closed to you" while only 18 (4.2%) disagreed and 51
(12.0%) moderately disagreed "to have nothing disclosed
to you". 13 (3.1%) respondents did not answer.
Intentions of creating a will
Lastly, 124 (29.2%) respondents claimed to have the
intention to create a will while only 39 (9.2%) have no
intention to do so. However, the majority of respondents
(254, 59.8%) specified as "undecided" in terms of intend-
ing to create a will. 8 (1.9%) respondents did not answer.
Bivariate analysis
Six factors were identified as significantly associated with
attitudes towards ADs: 1) experience with hospitalization
and death (χ2= 6.5, p < 0.05), 2) awareness regarding liv-
ing wills (χ2= 36.7, p < 0.001), 3) experience with the use
of ADs (χ2 = 20.2, p < 0.001), 4) preferences for end-of-life
treatment (χ2 = 28.9, p < 0.001), 5) preferences for infor-
mation disclosure (χ2= 21.6, p < 0.001), and 6) intentions
of creating a will (χ2= 22.9, p < 0.001). Socio-demo-
graphic factors such as sex, age, education, religion as well
as self-rated health status were not significantly
associated.
Multivariate analysis (Table 5)
Factors significantly associated with attitudes towards ADs
in bivariate analyses were entered into the multivariate
regression model controlling sex, age, education, religion
and health status. Ages were entered as dummy variables.
Significant factors were the following five: 1) awareness
regarding living wills, 2) experience with the use of ADs,
3) preferences for end-of-life treatment, 4) preferences for
information disclosure, and 5) intentions of creating a
will. Experience with death was narrowly eliminated, pos-
sibly due to its association with experience with the use of
ADs.
Discussion
The aim of the present study was to delineate layperson's
preferences, attitudes and behavior towards ADs and to
determine the factors associated with those attitudes in
Japan. Consequently, such data will serve as a foundation
for later investigation on suitable ways of implementing
ADs.
Results agree with previous studies in that the majority of
individuals responded in favor of expressing their direc-
tives beforehand [20–22]. Among those who lay in favor
of ADs, the results of the present study indicate that:
1) The most important components to be addressed are
the specifics of medical treatment at the end of life stage
and disclosure of diagnosis and prognosis;
2) The majority of participants found it suitable to express
their directives by word to family and/or physician and
not by written documentation;
Table 4: Reasons against the use of ADs (n = 83)
Questions Yes (%)
My family will make such decisions when the time is 
needed.
42 (50.6)
My physician will make such decisions when the time 
is needed.
35 (42.2)
I am currently healthy and there is no need to 
consider such decisions.
37 (44.6)
At my present age, there is no need to consider 
such decisions.
12 (14.5)
I have no information about ADs etc. 18 (21.7)
I feel that I will never be in situation where I would 
need an AD.
6 (7.2)
It is impossible to thing of such decisions for it is 
impossible to imagine oneself in such a situation.
45 (54.2)
I do not want to think that I will eventually die or 
loose my memory.
13 (15.7)
Others 8 (9.6)
Above are obtained from those who chosen either "strongly disagree" 
or "moderately disagree" in question 3 (preference toward ADs). 
Data indicate the number of respondents who marked each item.BMC Medical Ethics 2003, 4 http://www.biomedcentral.com/1472-6939/4/5
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3) There is no strong need for legal measures in setting up
an AD;
4) It is permissible for family and physician to loosely
interpret one's directives;
5) The most suitable proxy is considered to be a family
member, relative, or spouse.
These results provide a representative description of the
general public's preferences and attitudes towards ADs in
Japan. Results indicate a tendency towards leaving leeway
for interpretation by those who one trusts and an avoid-
ance away from the establishing of "set-guidelines" and
documents, especially legal forms.
The lack of need for legal documents
In Japan, there has been a historical lack of rights assertion
and of the employment of legal documents [23,24].
Although the issue of ADs and their possible legalization
have been discussed in the past [24], as to this date in
Japan, no advance directives including living wills from
organizations such as the Japan Society for Death and
Dying are legally binding.
This lies partly due to the fact that rights talk in Japan con-
notes a situation of conflict. As Feldman comments [23],
Rights talk in Japan appears most likely to be used in con-
flicts where there is more than one individual who
believes s/he is aggrieved. Because the cultural myths
about rights powerfully suggest that asserting rights is a
sign of selfishness and conceit, people are understand-
ingly reluctant to individually and in isolation assert their
rights (pp. 163)
With this in mind, the legalization of ADs may appear not
as an authentication of the documents but rather as an
instigation of "rights talk." However, we are not propos-
ing that Feldman's explanation of rights talk as being con-
flictive is justification of using oral ADs over written ones;
rather, we are suggesting that the sociological connota-
tions involved with legal documents is a factor behind the
evasion from the legalization of ADs.
Expression of one's will: (Oral or written)
Results indicate that oral ADs may be considered a suita-
ble approach to implementing ADs in Japan. However, in
cases when one wishes to make certain that directives are
carried out aptly, a written document may become neces-
sary. Oral ADs are often forgot, misinterpreted, or may not
be directly conveyed to one's medical providers. Accord-
ingly, we propose the usage of a written document (an
unofficial, non-legal form will do) in the following cases:
1) when one wants to make certain that all expressed
determinants are recognized and followed strictly; and/or
Table 5: Correlates for positive preference towards ADs
Correlates b Beta p value
Experience with hospitalization and death (Yes = 1) 0.072 0.052 0.312
Awareness regarding living willsa 0.153 0.167 0.001**
Experience with the use of ADs (Yes = 1) 0.247 0.126 0.019*
Preference for end-of-life treatmentb 0.158 0.161 0.002**
Preference for information disclosurec 0.087 0.105 0.043*
Intentions of creating a willd 0.193 0.127 0.015*
Sex (Male = 1) -0.101 -0.073 0.165
Age
20's 0.164 0.098 0.167
30's 0.105 0.054 0.409
40's 0.123 0.073 0.304
50's 0.068 0.043 0.529
60's Baseline category
Educatione 0.067 0.049 0.371
Religionf 0.019 0.011 0.822
Self-rated Health Statusg -0.068 -0.065 0.201
R2 0.17
Symbols indicate level of significance: *p < 0.05, **p < 0.01. Preference toward ADs (dependent variable): Strongly agree = 4, Moderately agree = 3, 
Moderately disagree = 2, Strongly disagree = 1, aYes = 3, Yes, but I am unsure of its meaning = 2, No = 1, b"Agree with b" = 4, "Fairly agree with b" 
= 3, "Fairly agree with a" = 2, "Agree with a" = 1, c"Agree with a" = 4, "Fairly agree with a" = 3, "Fairly agree with b" = 2, "Agree with b" = 1, dYes = 
1, No or Undecided = 0, eUniversity/College or more = 1, Junior College, High school, Junior high school = 0, fBuddhism, Shinto, Christian, and 
others = 1, None = 0, gGood = 4, Fairly good = 3, Fairly poor = 2, Poor = 1.BMC Medical Ethics 2003, 4 http://www.biomedcentral.com/1472-6939/4/5
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2) when one's medical providers feel that a written docu-
ment will be needed for evidence-related reasons.
The issue of leeway: situational decision-making
While the above explanation elucidates the possible fac-
tors behind the oppositions towards legal documents, it
leaves us with the question of why the circumvention
from non-legal written ADs and why the extensive range
of leeway.
The issue of leeway and the apparent circumvention from
written ADs can be deconstructed by understanding the
held conception that one's views and attitudes concerning
an event are greatly influenced by how one perceives the
event while experiencing it. Konishi and Davis suggest
that this type of situational decision-making is considered
the norm in Japanese health care [25]. Situational deci-
sion-making is indicative of one's relative position in the
context of the situation influences how one subjectively
perceives appropriate action.
ADs oppose this way of thinking for one is forced to make
end-of-life decisions without being able to experience his
or her relative position in the context of the situation.
Those who are against ADs responded that "people had
no ability to imagine the exact circumstances that lay
ahead" and that "there is great concern as to whether or
not one can predict beforehand one's intentions in
regards to an event that lies ahead without having experi-
enced such." Needless to say, this exemplifies recognition
of the logical limitations of ADs and furthermore
describes the inclination to situational decision-making.
These limitations are overcome by entrusting one's deci-
sions to a trusted family member or friend who is capable
of making decisions upon actually experiencing the situa-
tion. Entrusting one's decisions in the context of medical
treatment to one's family, close ones or medical profes-
sionals has been regarded as a dominant cultural charac-
teristic of Japanese health care [14,26–28], though this is
not strict to Japan [29].
Considering the minority
Results of this study show that only a minority of people
hold or intend to create an AD. These results parallel a pre-
vious report, where only 10% to 25% of patients ever
complete an AD of any sort [30]. However, the fact that
only a minority of patients is requesting the advocacy and
use of ADs does not make their use any less imperative.
In the present study, although the majority of participants
expressed the need for leeway, and no strong need for
legalization, a certain number of individuals have
expressed the need for ADs "to be as specific as possible,"
"to be followed in the strictest of terms," and "to undergo
legalization." We need to recognize that not all patients of
a single culture fit the characteristics of the majority. That
is, although most patients in Japanese society can be
described by the characteristic of situational decision-
making, we need to accommodate those who wish to use
a written AD; only by doing so are we capable of actually
respecting each individual's way of thinking.
Defining the minority in a homogenous culture: sub-
cultures
Cultural differences between physicians and patients have
been considered to intensify the process of making end-
of-life decisions [12]. In Japan, current sociological
changes in family dynamics indicate a possible need for a
proxy who can represent the individual's values and
beliefs. We propose that the use of an AD is necessary in
such cases where the values of patient and family differ. In
this sense, even within the same homogenous culture and
ethnicity, individual patients may diverge sub-culturally;
that is, cross-cultural dilemmas inevitably exist even
within the same culture [11,13].
The first step to appropriately deal with this cross-cultural
divergence that exists within a single culture and ethnicity
is to understand the actual perspectives of patient and
family [12,31]. The next is to define a treatment plan that
is acceptable both to the patient and family, and to the
health care team. In short, the key is effective communica-
tion between patient and health care staff, family and
health care staff. Bowman et al. proposes that "when
health care workers are unsure of how a patient or family
perceive a situation, it is best to simply ask. The mere
acknowledgement of such differences frequently leads to
improved communication" [12]. Further models for
cross-cultural clinical encounter have been developed
[32]. We suggest that models for cross-cultural clinical
encounter be applied to patients even within the same cul-
ture and ethnicity in order to fully understand each patient
as an individual with his or her own respective sub-cul-
ture.
ADs for information disclosure
Results showed that the ADs should contain the compo-
nent of assuring full disclosure of diagnosis and progno-
sis. This issue of information disclosure may be unique to
Japan's clinical medicine. Historically speaking, full dis-
closure of one's diagnosis and prognosis has not been the
norm; many patients in Japan have voiced that they
would rather be told a white lie of having gastric ulcers,
even if the truth is subliminally understood, over being
disclosed the terrifying truth of having stomach cancer
[26,27]. Japan's ADs are unique in that they often serve as
directives concerning one's preferences for being disclosed
medical information (i.e. diagnosis and prognosis). As
proposed in a previous report, ADs can be used as direc-BMC Medical Ethics 2003, 4 http://www.biomedcentral.com/1472-6939/4/5
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tives for disclosure "as a verbal or written declaration from
the patient that indicates his or her preference for disclo-
sure of information in the event cancer is diagnosed" [26].
In this sense, ADs can act as documented testimonies
ensuing either (1) full disclosure of information directly
to the patient and not via the family, or (2) nondisclosure
of one's diagnosis often as in the case of cancer. This com-
ponent of Japanese ADs can serve as a mediating tool to
the growing divergence between patients who prefer to be
disclosed all medical information and those patients who
prefer nondisclosure. Although several previous reports
have referred to this type of approach when discussing the
issue of information disclosure [26,33,34], this study is
the first to reconfirm researchers' propositions with the
general public's preferences.
Multivariate analysis: associative factors
Multivariate analysis revealed approximately five factors
associated with one's disposition towards ADs. Results
concerning one's level of awareness and personal experi-
ence with ADs were both directly associated with one's
preference towards them. Avoidance from ADs may be
related to one's lack of awareness and experience with
them. Although one previous report claims that "no evi-
dence [was found] that lack of knowledge about Living
Wills or proxy directives was a reason from patients not
completing such documents" [11], our findings are con-
sistent with several other studies where awareness, educa-
tion, and experience with ADs were found to be
significant associative factors in completion rates of ADs
[1,35–37]. Moreover, the factor of considering end-of-life
treatment decisions and information disclosure tells us
that those who have a firm stance regarding future medi-
cal treatment are more comfortable with the idea and use
of ADs. The factor of intending to create a will may exist
as an associated factor due to their similarity as "planning
ahead" strategies.
Previous reports describe that the factor of age is associ-
ated with the process of execution or nonexecution of ADs
[36–38]. This report diverges from previous results in that
age was not seen as a significant factor; we believe this is
due to the difference in sampling. Gordon and colleagues'
study used a sample ranging in age from 60 years and
above; Cook and colleagues incorporated a sample
restricted to intensive-care-unit patients averaging with a
mean age of over 60 years; and lastly, Havens' conducted
a systematic random sampling of those names listed in a
telephone book in which the mean was over the age of 50
years. In contrast to these non-stratified samples, this
survey has utilized a stratified random sampling from the
residential registry. In light of this fundamental difference
in sampling, we are unsure as to whether the incongruity
regarding the factor of age was due to differences in statis-
tical measures or due to differences in the nature of sam-
pling pools, i.e. city population, national characteristics,
ethnicity.
Limitations
This study's sampling is limited to residents who reside in
a condensed metropolitan area of Japan. Further research
is needed comparing our results with similar data col-
lected in rural area. However, this research provides the
first in-depth questionnaire survey with a systematic strat-
ified sampling focusing on the utilization of ADs in detail.
We recognize the need for further research concerning dis-
ease-specific ADs and further the implementation of
advance care planning in the clinical setting.
Conclusions
This study identified the preferences and attitudes towards
ADs; major findings included an expressed degree of lee-
way for interpretation of one's AD by one's physician and
family, a need for ADs to ensure the observance of one's
directives in the cases of terminal illness, brain death, and
pain treatment, as well as regarding information disclo-
sure, and lastly, a lack of strong need for legal measures in
setting up an AD. Results were also able to delineate five
factors significantly associated with preferences: 1) aware-
ness regarding living wills, 2) experience with the use of
ADs, 3) preferences for end-of-life treatment, 4) prefer-
ences for information disclosure, and 5) intentions of cre-
ating a will.
In light of these findings, we surmise that written ADs
might be useful in the Japanese setting when the individ-
ual either wishes: 1) to not provide a lot of leeway to sur-
rogates and/or caregivers, and/or 2) to ensure his or her
directives in the cases of terminal illness, brain death, and
pain treatment, as well as regarding information
disclosure.
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